Buloxibutid

DB18038InvestigationalSmall molecule

Buloxibutid: Overview.

Chemical structure of Buloxibutid
Formula / weight
C23H29N3O4S2 · 475.62 g/mol (avg)
Also known as
Butyl [3-[4-[(1H-imidazol-1-yl)methyl]phenyl]-5-isobutylthiophen-2-yl]sulfonylcarbamate · butyl [3-{4-[(1H-imidazol-1-yl)methyl]phenyl}-5-(2-methylpropyl)thiophene-2-sulfonyl]carbamate · Carbamic acid, [[3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]-, butyl ester · COMPOUND 21 · T2 AGONIST COMPOUND 21
Code names
C-21

Resolves to

Compound
UNIIRC2V4W0EYCCAS477775-14-7ChEMBLCHEMBL189568
Structure
InChIKeyXTEOJPUYZWEXFI-UHFFFAOYSA-NSMILESCCCCOC(=O)NS(=O)(=O)C1=C(C=C(CC(C)C)S1)C1=CC=C(CN2C=CN=C2)C=C1
Targets
P50052AGTR2

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Buloxibutid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In